LINZESSÂ® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBSâC) and chronic idiopathic constipation (CIC). Idiopathic means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children less than 18 years of age.
The Baylor Plan is developed by Baylor administrators during the Great Depression to help area citizens afford hospital care. It is the first prepaid hospital insurance plan in the United States and predecessor of Blue Cross.
The WVUCI Data and Safety Monitoring Plan (DSMP) outlines our commitment to human subject protections in clinical trials at this institution. It is the framework for ensuring that all clinical trials conducted by the WVUCI adhere to the appropriate regulations and policies established by federal and local authorities.